SCHEMBL1824709

SCHEMBL1824709

COC(=O)CC(c1ccc(OS(C)(=O)=O)cc1)C(N)Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.43
KCNA5 P22460 3/20 0.43
PLA2G1B P04054 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41
MAOB P27338 1/20 0.40
ABCB1 P08183 2/20 0.39
MMP1 P03956 2/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
PPARG P37231 2/20 0.39
ANPEP P15144 1/20 0.38
MMP9 P14780 1/20 0.38
MMP13 P45452 1/20 0.38
STS P08842 1/20 0.38
PPARA Q07869 2/20 0.38
CA1 P00915 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1824288 0.91 PLA2G1B (0.43) LTA4HKCNA5PLA2G1BATG4BMAOB
SCHEMBL1826619 0.89 PPARG (0.44) LTA4HPPARGSTSPPARA
SCHEMBL1827077 0.89 TSHR (0.42) LTA4HPLA2G1BATG4BPPARGSTS
SCHEMBL1825925 0.89 SLC15A1 (0.48) LTA4HABCB1PPARGSTSPPARA
SCHEMBL1823396 0.89 LTA4H (0.42) LTA4HKCNA5PLA2G1BATG4BMMP1
SCHEMBL1827164 0.88 MTNR1A (0.43) LTA4HKCNA5ACHEMEN1KMT2A
SCHEMBL1823214 0.88 CA2 (0.43) LTA4HABCB1PPARGSTSPPARA
SCHEMBL1824044 0.85 P2RX7 (0.46) PPARGMEN1KMT2AALDH1A1
SCHEMBL1822808 0.84 PLA2G1B (0.39) KCNA5PLA2G1BATG4BMAOBABCB1
SCHEMBL1824254 0.84 CA1 (0.45) LTA4HKCNA5PLA2G1BATG4BABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 LTA4H 3852/4885KCNA5 1251/4885PLA2G1B 4470/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 LTA4H 3332/4885KCNA5 1899/4885PLA2G1B 4673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.